Pet Service Holding Achieves Significant Growth Driven by Strategic Acquisition

Strategic Expansion Propels Pet Service Holding to New Financial Heights
Navigating Regulatory Changes and Boosting Revenue Streams
In the fiscal year concluding December 31, 2025, the Dutch pet care enterprise, Pet Service Holding (PSH), registered an impressive €13.6 million ($16M) in revenue, marking a 7.7% surge from the previous year. The first half of 2025 was particularly robust, contributing €7 million ($8.2M), a 14% uplift compared to the same period in 2024. This growth was spurred by the success of its online consumer platforms and its sales efforts targeting professionals. However, the latter half of 2025 saw a more tempered increase, with revenues reaching €6.5 million ($7.6M), reflecting a 3% rise over the prior year.
Adapting to Regulatory Frameworks and Mitigating Revenue Impact
PSH confronted a significant challenge last year when the Netherlands Food and Consumer Product Safety Authority (NVWA) mandated that certain prescription-only veterinary medicines could not be sold online in other EU member states. In compliance, PSH ceased these specific sales outside the Netherlands in the final quarter of 2025, leading to an estimated €1 million ($1.2 million) revenue shortfall during that period. To counteract these losses, the company is intensifying its focus on expanding its range of over-the-counter (OTC) veterinary products, pet accessories, and supplies, alongside investing further in its digital platforms.
Strategic Acquisition of Petlux Fuels Future Growth
August 2025 marked a pivotal moment for PSH with the acquisition of Petlux, a pet product manufacturer and distributor situated in Woerden, near Amsterdam. PSH's CEO, Ron van Veldhoven, indicated that Petlux's performance aligns with expectations, with integration efforts taking precedence to pave the way for future expansion. While Petlux's financial contribution in 2025 was modest due to the timing of the acquisition, it is anticipated to be a significant growth driver from 2026 onwards, bolstered by its strong product portfolio and existing European distribution network. This acquisition also plays a crucial role in PSH's strategy to diversify its revenue streams and reduce its reliance on activities sensitive to regulatory changes, aligning with its broader goal of shifting towards scalable, less regulation-dependent product categories.
Elevated Market Presence Through Stock Exchange Advancement
On July 28, 2025, PSH's shares transitioned from the Euronext Access+ index to the more prominent Euronext Growth Paris index on the Paris Stock Exchange. This move signifies PSH's evolution from a small-to-medium-sized enterprise (SME) to a larger entity with increased capital. Euronext acknowledged PSH's robust, integrated business model—encompassing veterinary pharmacies, wholesalers, online shops, and digital platforms—positioning it well within the expanding European pet market. While this upgrade necessitated additional costs to meet stringent listing requirements, including audited financial reporting, the enhanced visibility and access to a broader, international investor base are seen as substantial strategic advantages, according to Ron van Veldhoven.